Introduction Duchenne muscular dystrophy (DMD) is a childhood onset muscular dystrophy
leading to shortened life expectancy. There are gaps in published DMD care guidelines …

The goals of this study were to describe the clinical course of skeletal, cardiac, and
gastrointestinal muscle manifestations and trends in age at diagnosis and survival of …

Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder that causes
progressive weakness and wasting of skeletal muscular and myocardium in boys due to …

Objective: Duchenne muscular dystrophy is the commonest genetic myopathy but there exist
a large number of inherited neuromuscular diseases which individually are very rare and …

Despite the early onset of clinical signs suggestive of Duchenne muscular dystrophy (DMD),
a diagnosis is often not made until four years of age or older, with a diagnostic delay of up to …

Introduction Duchenne muscular dystrophy (DMD) is the most common form of muscular
dystrophy in children, affecting approximately one in 3,500–5,000 liveborn boys. The main …

Duchenne muscular dystrophy (DMD) is an recessive X-linked mediated, musculoskeletal
disorder that affects only males. It is the most common and severe form of muscular …

Introduction Duchenne muscular dystrophy (DMD) is the most common inherited muscle
disease in children. Recent years have seen an increase in age of survival into adulthood …

A coordinated, multidisciplinary approach to care is essential for optimum management of
the primary manifestations and secondary complications of Duchenne muscular dystrophy …

Treatment for DMD is a rapidly changing field. Some of the drugs that are currently under
investigation will receive Food and Drug Administration approval in the near future. These …